QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 54 of its Science Bytes ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of ...

Triage Plus was designed to detect mRNAs and DNA single-nucleotide variants from fibroblast growth factor receptor 3 and telomerase reverse transcriptase genes associated with bladder cancer.

The global lateral flow assay (LFA) components market is poised for significant growth, projected to reach USD 486.2 million ...

BD (Becton, Dickinson and Company) recently expanded its European infectious disease diagnostics portfolio after IVDR ...

IntroductionThe global critical care diagnostics market is poised for steady expansion, projected to grow at a CAGR of around 6% over the next five years. This growth trajectory is supported by ...

Siemens Healthineers AG became the latest company to sign a licensing agreement with Alzpath Inc. to use its pTau217 antibody in the development of a blood-based diagnostic assay for Alzheimer's ...

Roche’s cobas BV/CV assay gains CE Mark, enabling accurate, rapid diagnosis of bacterial vaginosis and candida vaginitis.

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

FDA expands labels for Roche's PATHWAY HER2 (4B5) test* and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now be used to identify HER2-positive metastatic breast cancer patients that could be ...

Gentian Diagnostics ASA ( ($DE:6FK) ) has issued an announcement. Gentian Diagnostics ASA reports continued solid progress in developing its ...

Roche has secured CE Mark approval for its cobas BV/CV assay to support the diagnosis of infectious causes of vaginitis.